O'Neill Kevin Michael 4
4 · GE HealthCare Technologies Inc. · Filed Mar 5, 2024
Insider Transaction Report
Form 4
O'Neill Kevin Michael
CEO, PDx
Transactions
- Tax Payment
Common Stock, par value $0.01 per share
[F1]2024-03-01$91.28/sh−1,309$119,486→ 27,691 total - Tax Payment
Common Stock, par value $0.01 per share
[F1]2024-03-01$91.28/sh−2,140$195,339→ 25,551 total - Tax Payment
Common Stock, par value $0.01 per share
[F1]2024-03-01$91.28/sh−1,717$156,728→ 23,834 total - Tax Payment
Common Stock, par value $0.01 per share
[F2]2024-03-01$91.28/sh−3,059$279,226→ 20,775 total - Award
Common Stock, par value $0.01 per share
[F3][F4]2024-03-01+3,235→ 24,010 total - Award
Employee Stock Option (right to buy)
[F5]2024-03-01+9,202→ 9,202 totalExercise: $92.72Exp: 2034-03-01→ Common Stock, par value $0.01 per share (9,202 underlying)
Holdings
- 59(indirect: By Trust)
Common Stock, par value $0.01 per share
Footnotes (5)
- [F1]Withholding of shares of GE HealthCare Technologies Inc. ("GE HealthCare") common stock to satisfy tax withholding obligations in connection with the vesting of restricted stock units.
- [F2]Withholding of shares of GE HealthCare common stock to satisfy tax withholding obligations in connection with the vesting of performance stock units previously reported by the reporting person in the Form 4 filed with the Securities and Exchange Commission on December 29, 2023.
- [F3]Award of restricted stock units with respect to GE HealthCare common stock, of which 33% will vest on September 1, 2025, 33% will vest on September 1, 2026, and 34% will vest on September 1, 2027, subject to certain conditions.
- [F4]Each restricted stock unit represents the right to receive, at settlement, one share of GE HealthCare common stock.
- [F5]Award of an employee stock option with respect to GE HealthCare common stock, of which 33% will become exercisable on September 1, 2025, 33% will become exercisable on September 1, 2026, and 34% will become exercisable on September 1, 2027, subject to certain conditions.
Signature
/s/ Frank R. Jimenez, General Counsel and Corporate Secretary, as attorney-in-fact|2024-03-05